Analysis of the Prognosis and Related Factors for Patients With Stage IV Gestational Trophoblastic Neoplasia
- 1 March 2014
- journal article
- research article
- Published by BMJ in International Journal of Gynecologic Cancer
- Vol. 24 (3), 594-599
- https://doi.org/10.1097/igc.0000000000000070
Abstract
Objective This study aimed to investigate and analyze the treatments and prognoses of patients with stage IV gestational trophoblastic neoplasia (GTN). Methods Between January 1990 and January 2010, 105 patients with stage IV GTN were treated in our hospital (Peking Union Medical College Hospital). A retrospective study is presented herein to report the prognoses of these patients and to statistically analyze the risk factors that affected the prognoses of patients with stage IV GTN. Results After the treatments, of the 105 patients, 71 (67.6%) patients achieved complete remission, 15 (14.3%) patients exhibited partial remission, and 19 (18.1%) patients exhibited progression of the disease. In total, of the 105 patients, 30 (28.6%) patients died. Our statistical analyses have revealed that a previously failed multidrug chemotherapy history, multiorgan metastasis concomitant with renal metastasis, and surgical intervention all affected the prognoses of patients with stage IV GTN. In addition, patients with stage IV GTN with International Federation of Gynecology and Obstetrics scores below 12 were relatively more likely to obtain complete remission. Conclusions Multidrug, multiroute chemotherapy, assisted by surgery when necessary, is the predominant strategy for patients with stage IV GTN. Fluorouracil-based multidrug chemotherapy can produce good outcomes for patients with stage IV GTN who were treated primarily. Adequate attention should be given to patients who have previously failed multidrug chemotherapy, have experienced multiorgan metastasis concomitant with renal metastasis, or have International Federation of Gynecology and Obstetrics scores of more than 12.Keywords
This publication has 13 references indexed in Scilit:
- The Role of Surgery in the Management of Gestational Trophoblastic NeoplasiaObstetrical & Gynecological Survey, 2013
- Role of Adjuvant Hysterectomy in Management of High-Risk Gestational Trophoblastic NeoplasiaInternational Journal of Gynecologic Cancer, 2012
- Etoposide, cisplatin–etoposide, methotrexate, actinomycin‐D as primary treatment for management of very‐high‐risk gestational trophoblastic neoplasiaInternational Journal of Gynecology & Obstetrics, 2011
- Salvage combination chemotherapy with floxuridine, dactinomycin, etoposide, and vincristine (FAEV) for patients with relapsed/chemoresistant gestational trophoblastic neoplasiaAnnals Of Oncology, 2011
- Surgical Resection in the Management of Pulmonary Metastatic Disease of Gestational Trophoblastic NeoplasiaInternational Journal of Gynecologic Cancer, 2009
- Gestational trophoblastic neoplasia: an update.Current Oncology Reports, 2008
- The practicability of FIGO 2000 staging for gestational trophoblastic neoplasiaInternational Journal of Gynecologic Cancer, 2004
- Treatment of high-risk gestational trophoblastic neoplasia with etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine chemotherapy☆Gynecologic Oncology, 2003
- Sequential use of methotrexate and actinomycin D in the treatment of metastatic choriocarcinoma and related trophoblastic diseases in womenAmerican Journal of Obstetrics and Gynecology, 1965
- Five years' experience with the chemotherapy of metastatic choriocarcinoma and related trophoblastic tumors in womenAmerican Journal of Obstetrics and Gynecology, 1961